Norbert Graf

22.2k total citations · 2 hit papers
459 papers, 11.2k citations indexed

About

Norbert Graf is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Norbert Graf has authored 459 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 234 papers in Molecular Biology, 131 papers in Pulmonary and Respiratory Medicine and 86 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Norbert Graf's work include Renal and related cancers (176 papers), Renal cell carcinoma treatment (99 papers) and Childhood Cancer Survivors' Quality of Life (49 papers). Norbert Graf is often cited by papers focused on Renal and related cancers (176 papers), Renal cell carcinoma treatment (99 papers) and Childhood Cancer Survivors' Quality of Life (49 papers). Norbert Graf collaborates with scholars based in Germany, United Kingdom and Netherlands. Norbert Graf's co-authors include Kathy Pritchard‐Jones, Ivo Leuschner, Rhoikos Furtwängler, Manfred Gessler, Harm van Tinteren, Marry M. van den Heuvel‐Eibrink, Gordan Vujanić, Jan Godziński, Harald Reinhard and Jan de Kraker and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Norbert Graf

438 papers receiving 10.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone

2005 505 citations Stefan Rutkowski, U. Bode et al. profile →
Reviewing the current state of virtual reality integration in medical education - a scoping review

2024 51 citations Norbert Graf et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Norbert Graf	6.0k	3.9k	2.2k	1.6k	1.2k	459	11.2k
Loreto Gesualdo	4.9k 0.8×	2.4k 0.6×	801 0.4×	2.0k 1.3×	827 0.7×	529	17.9k
Michiaki Kubo	5.1k 0.8×	2.0k 0.5×	664 0.3×	2.0k 1.3×	601 0.5×	385	18.3k
Jeffrey P. Krischer	2.6k 0.4×	2.3k 0.6×	1.0k 0.5×	1.4k 0.9×	1.7k 1.4×	353	17.8k
John J. Mulvihill	2.7k 0.4×	1.3k 0.3×	2.8k 1.3×	2.8k 1.7×	463 0.4×	249	12.7k
Augustinus A. M. Hart	6.3k 1.0×	2.2k 0.6×	828 0.4×	4.6k 2.8×	360 0.3×	105	15.1k
Gregory H. Reaman	4.2k 0.7×	2.1k 0.5×	4.9k 2.3×	3.6k 2.2×	2.7k 2.3×	306	15.8k
Brad H. Pollock	1.2k 0.2×	1.1k 0.3×	1.7k 0.8×	1.5k 0.9×	466 0.4×	213	8.5k
Stephen E. Sallan	6.3k 1.0×	2.6k 0.7×	6.4k 2.9×	4.0k 2.5×	2.3k 2.0×	282	21.5k
Ian Lewis	1.8k 0.3×	2.5k 0.6×	648 0.3×	1.4k 0.8×	201 0.2×	154	6.5k
Peter J. Morris	2.8k 0.5×	2.1k 0.5×	815 0.4×	2.0k 1.2×	324 0.3×	582	21.4k

Countries citing papers authored by Norbert Graf

Since Specialization

Citations

This map shows the geographic impact of Norbert Graf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Graf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Graf more than expected).

Fields of papers citing papers by Norbert Graf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Graf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Graf. The network helps show where Norbert Graf may publish in the future.

Co-authorship network of co-authors of Norbert Graf

This figure shows the co-authorship network connecting the top 25 collaborators of Norbert Graf. A scholar is included among the top collaborators of Norbert Graf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norbert Graf. Norbert Graf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Obrecht, Denise, Pablo Hernáiz Driever, Axel Sauerbrey, et al.. (2024). Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies. Neuro-Oncology. 26(11). 2125–2139. 1 indexed citations

Jackson, Thomas J., Hervé J. Brisse, Kathy Pritchard‐Jones, et al.. (2022). How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group. Pediatric Blood & Cancer. 69(9). e29702–e29702. 16 indexed citations

Mifsud, William, Rhoikos Furtwängler, Christian Vokuhl, et al.. (2022). Treatment of patients with stage I focal anaplastic and diffuse anaplastic Wilms tumour: A report from the SIOP-WT-2001 GPOH and UK-CCLG studies. European Journal of Cancer. 166. 1–7. 3 indexed citations

Krijger, Ronald R. de, Marjolijn C.J. Jongmans, Roland P. Kuiper, et al.. (2021). Clinical and Molecular Characteristics and Outcome of Cystic Partially Differentiated Nephroblastoma and Cystic Nephroma: A Narrative Review of the Literature. Cancers. 13(5). 997–997. 11 indexed citations

Vujanić, Gordan, Ellen D’Hooghe, Norbert Graf, et al.. (2021). Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK‐CCLG and GPOH studies. International Journal of Cancer. 149(6). 1332–1340. 11 indexed citations

Irtan, Sabine, Harm van Tinteren, Norbert Graf, et al.. (2019). Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial. European Journal of Cancer. 116. 13–20. 21 indexed citations

Fleischhack, Gudrun, Maura Massimino, Monika Warmuth‐Metz, et al.. (2019). Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study. Journal of Neuro-Oncology. 143(1). 107–113. 30 indexed citations

Hol, Janna A., Marta López‐Yurda, Harm van Tinteren, et al.. (2019). Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001. PLoS ONE. 14(8). e0221373–e0221373. 28 indexed citations

Rossi, Simona, Stefan Rüping, Francesca M. Buffa, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 5. 218–218. 8 indexed citations

10.

Schröder, Christina, Stephan Kiefer, Nikolaus Forgó, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 8. 401–401. 2 indexed citations

11.

Seravalli, Enrica, Christian Ruebe, D. M. Saunders, et al.. (2016). Improved Target Coverage While Simultaneous-Integrated-Sparing of Kidney and Liver by VMAT in Children Undergoing Whole-Abdomen Irradiation for Wilms Tumour. Data Archiving and Networked Services (DANS). 1 indexed citations

12.

Dome, Jeffrey S., Norbert Graf, James I. Geller, et al.. (2015). Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. Journal of Clinical Oncology. 33(27). 2999–3007. 235 indexed citations

13.

Tinteren, Harm van, Gordan Vujanić, Kathy Pritchard‐Jones, et al.. (2014). TREATMENT OF RELAPSED WILMS TUMOUR (WT) PATIENTS: EXPERIENCE WITH TOPOTECAN. Data Archiving and Networked Services (DANS). 3 indexed citations

14.

Creutzig, Ursula, Martin Zimmermann, Jean‐Pierre Bourquin, et al.. (2013). Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004. Blood. 122(1). 37–43. 123 indexed citations

15.

Graf, Norbert, Harm van Tinteren, Christophe Bergeron, et al.. (2012). Characteristics and outcome of stage II and III non-anaplastic Wilms’ tumour treated according to the SIOP trial and study 93-01. European Journal of Cancer. 48(17). 3240–3248. 61 indexed citations

16.

Pritchard‐Jones, Kathy, Norbert Graf, Christophe Bergeron, et al.. (2011). Doxorubicin can be safely omitted from the treatment of stage II/III, intermediate risk histology wilms tumour: results of the siop wt 2001 randomised trial [Abstract]. ORCA Online Research @Cardiff (Cardiff University). 1 indexed citations

17.

Graf, Norbert, Harm van Tinteren, Kathy Pritchard‐Jones, et al.. (2011). Is the absolute blastema volume after preoperative chemotherapy in nephroblastoma relevant for prognosis? [Abstract]. ORCA Online Research @Cardiff (Cardiff University). 4 indexed citations

18.

Oldenburger, Foppe, et al.. (2011). IS THE RADIOTHERAPY BOOST TO MACROSCOPIC RESIDUAL TUMOR INDICATED?. UCL Discovery (University College London). 1 indexed citations

19.

Williams, Richard D., Reem Al‐Saadi, Tasnim Chagtai, et al.. (2010). Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor. Clinical Cancer Research. 16(7). 2036–2045. 55 indexed citations

20.

Grundy, Paul, et al.. (2010). SIGNIFICANCE OF LYMPH NODE INVOLVEMENT IN NEPHROBLASTOMA. UCL Discovery (University College London). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact